SI2209784T1 - Spojine za zdravljenje hepatitisa C - Google Patents

Spojine za zdravljenje hepatitisa C

Info

Publication number
SI2209784T1
SI2209784T1 SI200830801T SI200830801T SI2209784T1 SI 2209784 T1 SI2209784 T1 SI 2209784T1 SI 200830801 T SI200830801 T SI 200830801T SI 200830801 T SI200830801 T SI 200830801T SI 2209784 T1 SI2209784 T1 SI 2209784T1
Authority
SI
Slovenia
Prior art keywords
hepatitis
compounds
treatment
Prior art date
Application number
SI200830801T
Other languages
English (en)
Inventor
Piyasena Hewawasam
Yong Tu
John A. Bender
Zhong Yang
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of SI2209784T1 publication Critical patent/SI2209784T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200830801T 2007-11-21 2008-11-19 Spojine za zdravljenje hepatitisa C SI2209784T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98952407P 2007-11-21 2007-11-21
PCT/US2008/083978 WO2009067481A1 (en) 2007-11-21 2008-11-19 Compounds for the treatment of hepatitis c
EP08852063A EP2209784B1 (en) 2007-11-21 2008-11-19 Compounds for the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
SI2209784T1 true SI2209784T1 (sl) 2013-02-28

Family

ID=40263273

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830801T SI2209784T1 (sl) 2007-11-21 2008-11-19 Spojine za zdravljenje hepatitisa C

Country Status (11)

Country Link
US (2) US8129367B2 (sl)
EP (2) EP2209784B1 (sl)
JP (1) JP5306366B2 (sl)
CN (1) CN101918406B (sl)
DK (1) DK2209784T3 (sl)
ES (1) ES2390732T3 (sl)
HR (1) HRP20120707T1 (sl)
PL (1) PL2209784T3 (sl)
PT (1) PT2209784E (sl)
SI (1) SI2209784T1 (sl)
WO (1) WO2009067481A1 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US8143243B2 (en) * 2007-08-09 2012-03-27 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8129367B2 (en) * 2007-11-21 2012-03-06 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
CN101977914A (zh) * 2008-03-27 2011-02-16 百时美施贵宝公司 用于治疗丙型肝炎的化合物
EP2280978B1 (en) * 2008-03-27 2013-04-24 Bristol-Myers Squibb Company Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors
JP2011515496A (ja) * 2008-03-27 2011-05-19 ブリストル−マイヤーズ スクイブ カンパニー ジオキソランおよびジオキソラノン縮合インドロベンザジアゼピンｈｃｖｎｓ５ｂ阻害剤
US8133884B2 (en) * 2008-05-06 2012-03-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
WO2012087833A1 (en) 2010-12-22 2012-06-28 Abbott Laboratories Hepatitis c inhibitors and uses thereof
US8716275B2 (en) * 2011-10-20 2014-05-06 Bristol-Myers Squibb Company Compound for the treatment of hepatitis C
AR089999A1 (es) * 2012-02-17 2014-10-01 Hoffmann La Roche Compuestos triciclicos y metodos para el uso de los mismos
EP2875030B1 (en) * 2012-07-18 2016-10-26 Bristol-Myers Squibb Holdings Ireland Methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3- methoxy-5a-((1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide
EP2792360A1 (en) 2013-04-18 2014-10-22 IP Gesellschaft für Management mbH (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
CN115856144B (zh) * 2022-12-19 2023-07-07 华夏生生药业(北京)有限公司 一种氟康唑原料药及注射液中三甲基碘化亚砜杂质的检测方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
PL1719773T3 (pl) 2004-02-24 2009-08-31 Japan Tobacco Inc Skondensowane związki heterotetracykliczne i ich zastosowanie jako inhibitora polimerazy HCV
US7348425B2 (en) * 2004-08-09 2008-03-25 Bristol-Myers Squibb Company Inhibitors of HCV replication
US7153848B2 (en) * 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
JP2008517986A (ja) 2004-10-26 2008-05-29 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー 抗ウイルス薬としての四環式インドール誘導体
GB0518390D0 (en) 2005-09-09 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
US7399758B2 (en) * 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7473688B2 (en) * 2005-09-13 2009-01-06 Bristol-Myers Squibb Company Indolobenzazepine HCV NS5B inhibitors
US7456165B2 (en) * 2006-02-08 2008-11-25 Bristol-Myers Squibb Company HCV NS5B inhibitors
GB0608928D0 (en) 2006-05-08 2006-06-14 Angeletti P Ist Richerche Bio Therapeutic agents
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7456166B2 (en) * 2006-05-17 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521441B2 (en) * 2006-05-22 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521442B2 (en) * 2006-05-25 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CN101490054B (zh) * 2006-05-25 2012-05-16 百时美施贵宝公司 环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂
US7452876B2 (en) * 2006-06-08 2008-11-18 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CA2672250C (en) * 2006-12-20 2013-04-30 Ian Stansfield Antiviral indoles
US7541351B2 (en) * 2007-01-11 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7517872B2 (en) * 2007-02-22 2009-04-14 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7998951B2 (en) * 2007-03-05 2011-08-16 Bristol-Myers Squibb Company HCV NS5B inhibitors
JP5211078B2 (ja) * 2007-03-13 2013-06-12 ブリストル−マイヤーズ スクイブ カンパニー シクロプロピル縮合インドロベンズアゼピンｈｃｖｎｓ５ｂ阻害剤
US7547690B2 (en) * 2007-03-14 2009-06-16 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7538102B2 (en) * 2007-03-14 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7521444B2 (en) * 2007-03-14 2009-04-21 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7541353B2 (en) * 2007-03-14 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7538103B2 (en) * 2007-03-15 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US20090018163A1 (en) * 2007-07-11 2009-01-15 Bristol-Myers Squibb Company Substituted Heterocyclic Ethers and Their Use in CNS Disorders
US7642251B2 (en) * 2007-08-09 2010-01-05 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7652004B2 (en) * 2007-08-09 2010-01-26 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
KR20100108341A (ko) * 2007-11-20 2010-10-06 브리스톨-마이어스 스큅 컴퍼니 시클로프로필 융합된 인돌로벤즈아제핀 ｈｃｖ ｎｓ5ｂ 억제제
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US8129367B2 (en) * 2007-11-21 2012-03-06 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C

Also Published As

Publication number Publication date
EP2518073B1 (en) 2015-08-26
EP2518073A1 (en) 2012-10-31
PL2209784T3 (pl) 2012-12-31
CN101918406A (zh) 2010-12-15
ES2390732T3 (es) 2012-11-16
US20120115847A1 (en) 2012-05-10
US20090130057A1 (en) 2009-05-21
CN101918406B (zh) 2013-04-17
HRP20120707T1 (hr) 2012-09-30
WO2009067481A1 (en) 2009-05-28
DK2209784T3 (da) 2012-10-29
JP2011504179A (ja) 2011-02-03
PT2209784E (pt) 2012-10-09
EP2209784B1 (en) 2012-08-01
EP2209784A1 (en) 2010-07-28
JP5306366B2 (ja) 2013-10-02
US8129367B2 (en) 2012-03-06

Similar Documents

Publication Publication Date Title
ZA200906129B (en) Compounds for the treatment of hepatitis c
ZA201105720B (en) Compounds for the treatment of hepatitis c
SI2209784T1 (sl) Spojine za zdravljenje hepatitisa C
ZA201000923B (en) Compounds for the treatment of hepatitis c
PT2303021T (pt) Compostos para tratamento do cancro
SI2001892T1 (sl) Spojine imidazolotiazol za zdravljenje proliferacijskih bolezni
HK1148435A1 (en) Oxadiazoanthracene compounds for the treatment of diabetes
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
ZA200907191B (en) Process for the preparation of gefitiib
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL211189A0 (en) Compounds for the treatment of peripheral neuropathies
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
IL243809A0 (en) Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds
ZA201001546B (en) Isoxazole compounds for the treatment of cancer
PL2896614T3 (pl) Sposoby i związki do wytwarzania normorfinanów
GB0602857D0 (en) The treatment of sialorrhoea
GB0717139D0 (en) Treatment of hepatitis C
TH0801003323A (th) สารประกอบสำหรับการบำบัดโรคตับอักเสบ c
GB0617310D0 (en) Treatment of hepatitis c
GB0719613D0 (en) The treatment of pruritis
GB0814997D0 (en) Processes for the preparation of compounds
GB0816217D0 (en) Treatment of hepatitis C
GB0817857D0 (en) Compounds for the treatment of neoplasia
GB0819536D0 (en) Compounds for the treatment of neoplasia